vs
Arteris, Inc.（AIP）与SUTRO BIOPHARMA, INC.（STRO）财务数据对比。点击上方公司名可切换其他公司
Arteris, Inc.的季度营收约是SUTRO BIOPHARMA, INC.的1.7倍（$20.1M vs $11.6M），Arteris, Inc.同比增速更快（30.0% vs -21.4%），过去两年Arteris, Inc.的营收复合增速更高（24.7% vs -5.4%）
Arteris公司是一家跨国科技企业，总部位于美国加利福尼亚州坎贝尔，主营片上网络（NoC）知识产权以及系统芯片（SoC）集成自动化软件的研发，产品用于各类半导体芯片与芯粒设计，客户覆盖汽车电子、人工智能、机器学习、企业计算、通信、消费电子、工业以及航空航天国防等多个领域。
Sutro Biopharma是一家上市生物科技公司，总部位于加州南旧金山，专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台，结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology，2009年改用现名。
AIP vs STRO — 直观对比
营收规模更大
AIP
是对方的1.7倍
$11.6M
营收增速更快
AIP
高出51.4%
-21.4%
两年增速更快
AIP
近两年复合增速
-5.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $20.1M | $11.6M |
| 净利润 | $-8.5M | — |
| 毛利率 | 90.8% | — |
| 营业利润率 | -42.0% | — |
| 净利率 | -42.2% | — |
| 营收同比 | 30.0% | -21.4% |
| 净利润同比 | -3.7% | 35.4% |
| 每股收益（稀释后） | $-0.19 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AIPSTRO
| Q4 25 | $20.1M | $11.6M | ||
| Q3 25 | $17.4M | $9.7M | ||
| Q2 25 | $16.5M | $63.7M | ||
| Q1 25 | $16.5M | $17.4M | ||
| Q4 24 | $15.5M | $14.8M | ||
| Q3 24 | $14.7M | $8.5M | ||
| Q2 24 | $14.6M | $25.7M | ||
| Q1 24 | $12.9M | $13.0M |
净利润AIPSTRO
| Q4 25 | $-8.5M | — | ||
| Q3 25 | $-9.0M | $-56.9M | ||
| Q2 25 | $-9.1M | $-11.5M | ||
| Q1 25 | $-8.1M | $-76.0M | ||
| Q4 24 | $-8.2M | $-72.4M | ||
| Q3 24 | $-7.7M | $-48.8M | ||
| Q2 24 | $-8.3M | $-48.0M | ||
| Q1 24 | $-9.4M | $-58.2M |
毛利率AIPSTRO
| Q4 25 | 90.8% | — | ||
| Q3 25 | 89.9% | — | ||
| Q2 25 | 89.4% | — | ||
| Q1 25 | 90.8% | — | ||
| Q4 24 | 89.8% | — | ||
| Q3 24 | 90.1% | — | ||
| Q2 24 | 90.0% | — | ||
| Q1 24 | 88.7% | — |
营业利润率AIPSTRO
| Q4 25 | -42.0% | — | ||
| Q3 25 | -50.1% | -499.9% | ||
| Q2 25 | -50.0% | -5.2% | ||
| Q1 25 | -46.6% | -393.8% | ||
| Q4 24 | -45.9% | -440.7% | ||
| Q3 24 | -53.8% | -797.2% | ||
| Q2 24 | -51.1% | -189.4% | ||
| Q1 24 | -70.5% | -435.0% |
净利率AIPSTRO
| Q4 25 | -42.2% | — | ||
| Q3 25 | -51.6% | -586.6% | ||
| Q2 25 | -55.3% | -18.0% | ||
| Q1 25 | -49.1% | -436.6% | ||
| Q4 24 | -53.0% | -489.2% | ||
| Q3 24 | -52.2% | -572.6% | ||
| Q2 24 | -57.2% | -186.8% | ||
| Q1 24 | -72.6% | -447.5% |
每股收益（稀释后）AIPSTRO
| Q4 25 | $-0.19 | — | ||
| Q3 25 | $-0.21 | $-0.67 | ||
| Q2 25 | $-0.22 | $-0.14 | ||
| Q1 25 | $-0.20 | $-0.91 | ||
| Q4 24 | $-0.19 | $-27.63 | ||
| Q3 24 | $-0.20 | $-0.59 | ||
| Q2 24 | $-0.22 | $-0.59 | ||
| Q1 24 | $-0.25 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $33.9M | $141.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-14.6M | $-132.5M |
| 总资产 | $115.0M | $173.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AIPSTRO
| Q4 25 | $33.9M | $141.4M | ||
| Q3 25 | $39.0M | $167.6M | ||
| Q2 25 | $38.0M | $205.1M | ||
| Q1 25 | $42.3M | $249.0M | ||
| Q4 24 | $43.8M | $316.9M | ||
| Q3 24 | $48.7M | $388.3M | ||
| Q2 24 | $45.8M | $375.6M | ||
| Q1 24 | $44.8M | $267.6M |
股东权益AIPSTRO
| Q4 25 | $-14.6M | $-132.5M | ||
| Q3 25 | $-11.4M | $-87.3M | ||
| Q2 25 | $-7.5M | $-32.1M | ||
| Q1 25 | $-4.8M | $-25.8M | ||
| Q4 24 | $-1.2M | $44.6M | ||
| Q3 24 | $2.2M | $111.2M | ||
| Q2 24 | $5.3M | $152.2M | ||
| Q1 24 | $9.5M | $98.0M |
总资产AIPSTRO
| Q4 25 | $115.0M | $173.8M | ||
| Q3 25 | $107.7M | $209.7M | ||
| Q2 25 | $106.9M | $262.4M | ||
| Q1 25 | $98.3M | $321.4M | ||
| Q4 24 | $106.1M | $387.2M | ||
| Q3 24 | $97.7M | $451.8M | ||
| Q2 24 | $96.4M | $489.0M | ||
| Q1 24 | $101.4M | $403.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.2M | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | $3.0M | — |
| 自由现金流率自由现金流/营收 | 15.1% | — |
| 资本支出强度资本支出/营收 | 0.7% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $5.3M | — |
8季度趋势，按日历期对齐
经营现金流AIPSTRO
| Q4 25 | $3.2M | $-177.2M | ||
| Q3 25 | $3.2M | $-38.2M | ||
| Q2 25 | $-2.5M | $-44.7M | ||
| Q1 25 | $2.9M | $-67.9M | ||
| Q4 24 | $-2.6M | $-71.7M | ||
| Q3 24 | $1.1M | $-64.5M | ||
| Q2 24 | $311.0K | $9.5M | ||
| Q1 24 | $477.0K | $-64.7M |
自由现金流AIPSTRO
| Q4 25 | $3.0M | — | ||
| Q3 25 | $2.5M | — | ||
| Q2 25 | $-2.8M | — | ||
| Q1 25 | $2.7M | — | ||
| Q4 24 | $-2.7M | — | ||
| Q3 24 | $1.1M | — | ||
| Q2 24 | $264.0K | — | ||
| Q1 24 | $281.0K | — |
自由现金流率AIPSTRO
| Q4 25 | 15.1% | — | ||
| Q3 25 | 14.2% | — | ||
| Q2 25 | -17.2% | — | ||
| Q1 25 | 16.2% | — | ||
| Q4 24 | -17.3% | — | ||
| Q3 24 | 7.4% | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | 2.2% | — |
资本支出强度AIPSTRO
| Q4 25 | 0.7% | — | ||
| Q3 25 | 4.1% | — | ||
| Q2 25 | 2.2% | — | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 1.5% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AIP
| License And Maintenance | $17.5M | 87% |
| Variable Royalties And Other | $2.6M | 13% |
STRO
暂无分部数据
